Breaks Categories: News

MondayMay 17, 2021 11:00 am

NetworkNewsBreaks – Healthtech Solutions Inc. (HLTT) Announces Strategic CEO Appointment

Healthtech Solutions (OTC: HLTT), the parent company of Varian Biopharmaceuticals Inc., Medi-Scan Inc. and RevHeart Inc., has announced its appointment of Edward (“Ned”) Swanson, M.D., as its chief executive officer. Dr. Swanson brings a unique background and skillset that is particularly well suited to lead Healthtech, combining scientific, clinical and industry knowledge. He is a co-founder of PolarityTE Inc., a biotech company developing various regenerative tissue products and biomaterials, led by its flagship product SkinTE(R). In his leadership roles with PolarityTE and its subsidiaries, Dr. Swanson gleaned deep industry knowledge and know-how related to company formation, financing, product development, medical…

Continue Reading

MondayMay 17, 2021 10:18 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Opens Flagship Store in Popular Canadian Destination

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the opening of its first Canadian brick-and-mortar store under the PlantX brand in Squamish, British Columbia (the "Squamish Flagship Location"). Per the update, the Squamish Flagship Location showcases a variety of carefully curated grocery and wellness items by popular Canadian and U.S. plant-based brands and aims to increase public engagement and plant-based education. "We are extremely pleased to announce the opening of PlantX's first brick-and-mortar store in beautiful Squamish, British Columbia," said PlantX CEO Julia Frank. "Squamish is a health-oriented town with a thriving vegan community and it is…

Continue Reading

MondayMay 17, 2021 9:58 am

NetworkNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) RYAH Medtech Enters Exclusive Agreement with DelleD SAS

RYAH Group’s (CSE: RYAH) wholly owned subsidiary, RYAH Medtech Inc., has entered a definitively exclusive software development and product distribution agreement with its France-based partner, DelleD SAS, for the distribution of the RYAH Smart Inhaler. According to the update, the strategic agreement further defines the previously announced arrangement with DelleD to distribute RYAH Smart Inhalers in the territory of France and participate in the upcoming tender for the French government’s national experiment on patient use of medical cannabis. “In addition to distribution of the proprietary devices and accessories, the deal involves a statement of work (‘SOW’) for RYAH to develop customized…

Continue Reading

FridayMay 14, 2021 2:06 pm

NetworkNewsBreaks – Wave Life Sciences Ltd. (NASDAQ: WVE) Featured in Mizuho Securities Research Report

Wave Life Sciences (NASDAQ: WVE) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “This morning, WVE held its 1Q21 call. We also had the opportunity to catch up with management post the call. The most important takeaway from today's call is that we now have a timeline as to when we can expect at least initial clinical data from Wave's new PN-chemistry based pipeline program(s) -- 2022. It's starting to set up as potentially as a really important year for the company in our view, if they produce multiple datasets, which…

Continue Reading

FridayMay 14, 2021 12:26 pm

NetworkNewsBreaks – Hunter Technology Corp. (TSX.V: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM) Announces May 17 Webcast

Hunter Technology (TSX.V: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM), a developer of digital marketplaces for global energy trading, has scheduled a webcast to connect with shareholders, investors and analysts. Hunter CEO Florian M Spiegl will host the webcast, which is scheduled for Monday, May 17, 2021, at 4:30 p.m. ET. Interested parties are encouraged to participate in the call and also submit questions before the call for Hunter Technology management to answer. Those questions can be sent via email at [email protected] or upon registering for the call. To register for the call, visit https://nnw.fm/OedYZ To view the full press…

Continue Reading

FridayMay 14, 2021 11:57 am

NetworkNewsBreaks – Knightscope Inc. Secures Additional $21.9M, Now Responsible for Two Largest Raises in StartEngine’s History

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has successfully completed its most recent public offering, raising an additional $21.91 million. According to the update, Knightscope has now completed the two largest funding rounds in the history of the StartEngine platform. Knightscope has raised $90+ million from more than 28,000 investors and is poised to be an industry leader in the future of public safety and security. In addition, the company has reserved ticker symbol ‘KSCP’ with Nasdaq and is contemplating a possible public listing. “Knightscope’s long-term vision has an eye on the greater…

Continue Reading

FridayMay 14, 2021 11:10 am

NetworkNewsBreaks – WAX Blockchain Partners with Additional Well-Loved Entertainment Brands to Launch Digital Collectibles

Worldwide Asset eXchange(TM) (“WAX”), the “King of NFTs,” today announced partnerships with a number of the world’s most well-loved entertainment brands to release digital collectibles, called NFTs, on the WAX blockchain. The new partnerships include Robotech (Funimation and Harmony Gold), Five Nights at Freddy's (ScottGames), Bears vs Babies (Exploding Kittens), and The Princess Bride (Act III). The new partners join existing WAX partners that have already released hugely successful products on WAX, including Topps (Major League Baseball, Godzilla, Garbage Pail Kids), Capcom (Street Fighter), Atari, DeadMau5, Weezer, Reebok, William Shatner, Leonard Nimoy, and many more. Additionally, beginning in June of…

Continue Reading

FridayMay 14, 2021 11:09 am

NetworkNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Designated as a Preferred Vendor by Visit Tampa Bay

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a leading provider of web-based augmented reality for e-commerce, advertising and virtual events, today announced a strategic partnership with Visit Tampa Bay. Designated as a preferred vendor by Visit Tampa Bay, the partnership affords the company the opportunity to connect with confirmed conferences for the city. Nextech is committed to building strategic partnerships with the world’s top destination marketing organizations and extending their reach through virtual and hybrid events. "We are thrilled to partner with Tampa Bay,” said Nextech CEO and Director Evan Gappelberg. “Nextech’s hybrid and virtual events platform keeps…

Continue Reading

FridayMay 14, 2021 10:58 am

NetworkNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Releases Q1 2021 Financial, General Meeting Report

Excellon Resources (TSX: EXN, EXN.WT) (NYSE American: EXN) (FSE: E4X2) has released its financial report for first quarter 2021, the period ended March 31, 2021. The report included both financial and operational highlights. Among the financial highlights for the company was the announcement that revenues had increased by 76% to $9.8 million during Q1 2020 compared to $5.6 million in Q1 2020, and gross profit reached $1.8 million, a $3 million improvement over first quarter 2020, which posted a $1.2 million loss. The company also reported total cash cost net of byproducts per silver ounce payable decreased by 13% to $13.43 compared to $15.35 the same quarter…

Continue Reading

FridayMay 14, 2021 10:58 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2021 Results, Provides Clinical Update and Business Outlook

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today provided a clinical update and business outlook and released its financial results for the quarter ended March 31, 2021. "2021 is poised to be an exciting year for the company. Throughout the first quarter, we have made continued development and regulatory progress on all fronts and are committed to driving our novel treatments forward as expeditiously as possible with the primary focus on our Berubicin program to improve patient outcomes for GBM," said…

Continue Reading